Vitaliy Sarkisyan

Recommended Articles

• Shapewear Garments May Help to Burn More Calories

  A new study has shown that women who wear tight shapewear garments during a workout will burn more calories compared to women who do not. The researchers from the University of Virginia say that these garments makes the muscles work harder and burn more calories.In this study, 15 women with the...

• Why Do Hallucinations Happen?

  IntroductionHallucinations are sensations that people perceive as real, but in reality, are only created by their mind. A person's five senses are often affected. Examples are hearing voices without anyone around or seeing images that are not real. Such symptoms are may due to mental illnesses, drug...

• Study Predicts 40 Million People with Diabetes Might Be Without Insulin by 2030

  According to a new study, diabetic patients' access to insulin may fall short by the year 2030. Diabetes diagnoses continue to rise in numbers, and it's predicted that approximately 79 million adults with type 2 diabetes will require insulin to manage it. Because of the current levels of insulin...

• Antidepressants May Offer Relief for Fibromyalgia Patients

  Today, nearly every condition that has been identified in the world of healthcare has a medication to treat it.  From heart-related issues to joint pain, drug companies have found ways to to relieve or reduce severity of some of symptoms a patient must endure.  In a study originally published in...

• Everything to Know About Celiac Disease

  There are many types of people who have allergies or are sensitive to certain foods. One of these allergies or sensitivities is gluten. Those who are sensitive to gluten are diagnosed with Celiac disease, which has a vast history that makes it a commonly known condition. But how exactly did Celiac...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...